Sedana Medical AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 44.54 million compared to SEK 35.81 million a year ago. Net loss was SEK 38.07 million compared to SEK 35.94 million a year ago.

Basic loss per share from continuing operations was SEK 0.38 compared to SEK 0.36 a year ago. Diluted loss per share from continuing operations was SEK 0.38 compared to SEK 0.36 a year ago.